Riskpilot← Back to searchSign inGet full accessAlaMedical AB
ABActiveOrg 5592409964Tunnbindaregatan 16 BHospital activities · NACE 8610Est. 20200 employees
Revenue 2024
SEK -1
-100% vs 2023
EBITDA margin
1550000.0%
-108% vs 2023
Equity ratio
90.9%
Financial strength
Net profit 2024
SEK -15K
-110% vs 2023
| Revenue | SEK -1 | -100% |
| EBITDA | SEK -16K | -108% |
| Net profit | SEK -15K | -110% |
| Total assets | SEK 172K | -30% |
| Equity | SEK 156K | -9% |
| Employees | 0 | — |
Legal name
AlaMedical AB
Org number
5592409964
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
6 februari 2020
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva konsultverksamhet inom hälso- och sjukvård. Konsultverksamheten kommer att yttra sig i form av att Alaa Mejaddam ska arbeta som stafettläkare inom både primärvård och slutenvård.
Address
Tunnbindaregatan 16 B
Email
alaa.mejaddam@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 137 | 91 | 183 | 202 | −0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 101 | 64 | 152 | 183 | −15 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 101 | 64 | 152 | 183 | −15 |
| Net financials | — | −1 | 0 | 0 | 0 |
| Profit before tax | 102 | 63 | 152 | 183 | −15 |
| Tax | −22 | −13 | −32 | −38 | — |
| Net profit | 80 | 50 | 121 | 145 | −15 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 149 | 187 | 200 | 244 | 172 |
| Equity | 105 | 155 | 146 | 171 | 156 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 44 | 33 | 55 | 73 | 16 |
| Total debt | 44 | 33 | 55 | 73 | 16 |
EBITDA margin
-1550000.0%
This company
15.8%
Market median
-9810227% vs market
20202024
Equity ratio
90.9%
This company
38.2%
Market median
+138% vs market
20202024
Return on equity
-9.8%
This company
18.4%
Market median
-153% vs market
20202024
Net profit margin
-1524600.0%
This company
8.1%
Market median
-18822322% vs market
20202024
Asset turnover
-0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-02-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of AlaMedical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Younes Mejaddam | Deputy Board Member | 0 companies |
| Ala Mejaddam | Board of Directors | 0 companies |